FDA Drug Recalls

Recalls / Class II

Class IID-0605-2022

Product

Severe Congestion Nasal Spray, No Drip Plus Menthol, Oxymetazoline HCl 0.05%, 1 FL Oz (30 mL) per bottle, DISTRIBUTED BY FOODHOLD U.S.A., LLC, LANDOVER, MD 20785. NDC 41520-108-10

Brand name
Careone Severe Congestion Nasal
Generic name
Oxymetazoline Hydrochloride
Active ingredient
Oxymetazoline Hydrochloride
Route
Nasal
NDC
41520-108
FDA application
M012
Affected lot / code info
Batch: 1BK0716, Exp 12/31/2022; 1FK1251, Exp 02/28/2023

Why it was recalled

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Recalling firm

Firm
Perrigo Company PLC
Manufacturer
American Sales Company
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
515 Eastern Ave, Allegan, Michigan 49010-9070

Distribution

Quantity
7,200 bottles
Distribution pattern
Nationwide in the USA

Timeline

Recall initiated
2021-10-26
FDA classified
2022-02-23
Posted by FDA
2022-03-02
Terminated
2023-09-29
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0605-2022. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: Careone Severe Congestion Nasal · FDA Drug Recalls